AuDHD clinical overview: what GPs need to know

Resource — For Clinicians

AuDHD clinical overview: what GPs need to know

AuDHD — the co-occurrence of autism and ADHD — affects an estimated 50–70% of autistic adults and up to 40% of adults with ADHD. As a GP, you are often the first point of clinical contact. This guide equips you to recognise the presentation, avoid common diagnostic pitfalls, and coordinate effective care.

What is AuDHD?

AuDHD refers to the co-occurrence of Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) in the same individual. Since the DSM-5 (2013) removed the exclusionary rule preventing dual diagnosis, research and clinical recognition of this profile has grown rapidly.

AuDHD is not simply "autism plus ADHD." The two conditions interact in ways that create a distinct clinical presentation. Traits can mask, amplify, or contradict each other — making identification significantly more complex than either condition alone.

Key point: A patient who appears "too social" for autism or "too focused" for ADHD may in fact have both. The conditions frequently mask each other in clinical settings.

Recognising AuDHD in primary care

Presentation patterns to watch for

Patients with AuDHD often present with a confusing mix of traits. They may describe intense focus on specific interests (autism) alongside an inability to sustain attention on anything else (ADHD). They may crave routine but struggle to maintain it. They may mask socially but experience severe burnout afterward.

Common presentations in general practice include chronic fatigue or burnout that does not respond to standard interventions, anxiety or depression that is treatment-resistant, executive function difficulties disproportionate to cognitive ability, sensory sensitivities affecting daily function, relationship difficulties with a pattern of misunderstanding, and repeated workplace difficulties despite evident competence.

The masking problem

Many AuDHD adults — particularly women, non-binary people, and those socialised as female — present with highly developed masking strategies. They may appear neurotypical in a 15-minute consultation. Look beyond surface presentation to functional impact: sleep quality, energy management, social recovery time, and sensory load.

Clinical tip: Ask about the "cost" of normal functioning. Questions like "What happens after a full day of work?" or "How long do you need to recover after social events?" can reveal hidden disability.

Common diagnostic pitfalls

Pitfall 1: Sequential diagnosis. Many patients receive an ADHD diagnosis first, then years later receive an autism diagnosis (or vice versa). Each condition alone fails to explain the full picture. If a patient has one diagnosis but remains functionally impaired despite treatment, consider assessment for the other.

Pitfall 2: Attributing everything to mental health. AuDHD is frequently misdiagnosed as anxiety, depression, bipolar disorder, borderline personality disorder, or complex PTSD. While these conditions can co-occur, treating them without addressing the underlying neurodivergence typically yields poor outcomes.

Pitfall 3: Using screening tools in isolation. Standard screening tools (AQ-10, ASRS) were not validated for dual presentations. A patient may score below threshold on both while clearly meeting criteria for each. Use screening tools as conversation starters, not gatekeepers.

Pitfall 4: Dismissing self-identification. Patients who present having researched AuDHD are frequently well-informed. Research shows that autistic self-identification has high concordance with formal diagnosis. Take self-referred patients seriously.

Referral pathways

Comprehensive AuDHD assessment is best conducted by a psychologist or psychiatrist experienced in adult neurodivergence, ideally one who understands the interaction between autism and ADHD. Single-condition assessors may miss the dual presentation.

When referring, provide a detailed history including developmental background (if available from parents or school reports), current functional difficulties across domains, previous diagnoses and treatment responses, and the patient's own observations about their neurocognitive profile.

Referral tip: Ask the assessor whether they are experienced in dual ASD/ADHD presentations specifically. An assessor skilled in one condition may inadvertently screen out the other.

Medicare considerations

Under current Medicare arrangements, patients can access psychological assessment through a Mental Health Treatment Plan. However, coverage is limited, and many comprehensive AuDHD assessments exceed the rebated sessions. Be transparent with patients about likely gap fees. AUDHD Australia is actively advocating for improved Medicare access to neurodevelopmental assessment.

Supporting your AuDHD patients

Communication adjustments

AuDHD patients benefit from clear, direct communication. Avoid ambiguous language. Provide written summaries of consultations. Allow processing time — many AuDHD adults need a moment to formulate verbal responses. Offer longer appointment slots where possible, as the standard 10-minute consult is rarely sufficient for complex neurodevelopmental care.

Medication management

Stimulant medication for ADHD can be effective in AuDHD, but the response profile may differ. Some patients experience increased sensory sensitivity or anxiety on stimulants. Start low, titrate slowly, and monitor for both ADHD symptom improvement and any exacerbation of autistic traits. Collaborative prescribing with a psychiatrist experienced in neurodivergence is ideal.

Holistic care

AuDHD is a whole-of-life condition, not a mental illness to be treated and resolved. Effective GP care includes ongoing monitoring of burnout risk, sensory environment assessment, sleep optimisation, nutritional support (disordered eating is prevalent), and coordination with allied health providers including occupational therapists, psychologists, and speech pathologists.

This resource is published by AUDHD Australia as general clinical guidance. It does not replace individualised clinical judgement. Last updated April 2026.